Methamphetamine-dependence Clinical Trial
Official title:
The Effect of Mindfulness-based Relapse Prevention on Impulsive Control Circuit Among Methamphetamine Dependents
Amphetamine-type stimulants (ATSs) have become the most important medical issue as well as the social problem. Compared with traditional drugs, ATS are highly neurotoxin and can induce cognitive deficit and psychotic symptoms. Due to lack of efficient medical treatment, psychotherapy and behavioral interventions are the main treatment strategies so far. Mindful-based relapse prevention (MBRP) which combined mindfulness with relapse prevention skills, as a novel intervention, has been widely used in prevent craving and relapse among addictions. While the current research of MBRP mechanism focus on emotion regulation circuit, and there was no study to explore the impulsive circuit, which is the important factor that induce the addiction and relapse. However, there was no report about the influence of MBRP on Prefrontal-striatal circuits. Based on the previous results, the proposed study will focus on evaluating the mechanism of MBRP on prefrontal-striatal circuits, neuropsychological tests and functional MRI will be used to investigate the neurobiological mechanism of MBRP on prefrontal-striatal circuits and related impulsive behaviors.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05916989 -
Stimulant Use and Methylation in HIV
|
||
Recruiting |
NCT04927143 -
Encouraging Abstinence Behavior in a Drug Epidemic
|
Phase 2 | |
Completed |
NCT04449055 -
Pilot TMS for Methamphetamine Use Disorder
|
N/A | |
Completed |
NCT06288997 -
tACS Intervention for Methamphetamine Addiction
|
N/A | |
Active, not recruiting |
NCT05162391 -
Inflammation in Methamphetamine and STIs (IMSTI)
|
N/A | |
Completed |
NCT03336866 -
Study of Antibody for Methamphetamine Outpatient Therapy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06233799 -
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
|
Phase 3 | |
Recruiting |
NCT03341078 -
Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users
|
Phase 2 | |
Active, not recruiting |
NCT03910608 -
Paired Associative Stimulation in Methamphetamine Addiction
|
N/A | |
Terminated |
NCT05283304 -
Monthly Injectable BUP for MA Use Disorder (MURB) Trial
|
Phase 2 | |
Completed |
NCT04563962 -
Contingency Management for PrEP Adherence and/or Methamphetamine Use
|
N/A | |
Not yet recruiting |
NCT05334914 -
ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals
|
N/A | |
Terminated |
NCT05034874 -
Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200
|
Phase 2 | |
Recruiting |
NCT06434818 -
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
|
Phase 2 | |
Recruiting |
NCT06027814 -
MHealth Incentivized Adherence Plus Patient Navigation
|
N/A | |
Completed |
NCT04544124 -
Delivering Contingency Management in Outpatient Addiction Treatment
|
N/A | |
Completed |
NCT01217970 -
Safety Interaction Trial Ibudilast and Methamphetamine
|
Phase 1 | |
Completed |
NCT03825536 -
Effect of Methamphetamine on Residual Latent HIV Disease Study
|
Phase 4 | |
Recruiting |
NCT03470480 -
rTMS for Craving in Methamphetamine Use Disorder
|
N/A | |
Recruiting |
NCT05128071 -
PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)
|
Early Phase 1 |